Digital Holographic Microscopy Emerges as Label Free Alternative for Long Term Live Cell Imaging and Drug Discovery

Benjamin Rappaz explains how Digital Holographic Microscopy provides label-free, quantitative data for long-term cell study and pharmaceutical screening.

By: AXL Media

Published: Apr 3, 2026, 12:23 PM EDT

Source: Information for this report was sourced from News-Medical.net

The Evolution of Quantitative Phase Imaging

Modern cell biology is increasingly moving toward imaging techniques that preserve the natural state of living organisms over extended observation periods. Digital Holographic Microscopy (DHM) has emerged as a sophisticated form of quantitative phase imaging that allows for the real time monitoring of cellular growth and stimuli responses without the need for traditional fluorescent dyes. According to Benjamin Rappaz, Head of Life Sciences at Lyncée Tec SA, DHM offers a label free alternative that quantifies essential parameters such as optical volume and cellular dry mass, providing a window into metabolic health that remains undisturbed by external markers.

Synergy Between Molecular Specificity and Morphological Data

While fluorescence microscopy remains a gold standard for identifying specific proteins and intracellular structures, it is often limited by signal degradation and bleaching. DHM complements these traditional methods by offering continuous, quantitative insights into mass distribution and cell morphology that fluorescence might otherwise obscure. By utilizing a multimodal approach, scientists can effectively link molecular level events captured via fluorescence with the dynamic, long term morphological shifts recorded through holography, resulting in a more comprehensive understanding of complex biological systems.

Validation Protocols for Industrial and Pharmaceutical Research

For DHM to be viable in pharmaceutical settings, its physical readouts must be reconciled with established biochemical markers. Validation frameworks typically involve creating initial calibration curves under strictly controlled conditions to demonstrate concordance between DHM derived metrics and orthogonal markers of cell viability. Because DHM measurements are rooted in fundamental physical principles, they offer a high level of intrinsic accuracy and reproducibility, making the technology particularly attractive for industrial partners who require reliable data for drug response assays.